BMC Nephrology | |
Factors associated with serum fetuin-A concentrations after long-term use of different phosphate binders in hemodialysis patients | |
Research Article | |
Ming-Shiou Wu1  Hung-Hsiang Liou2  Hsin-Hung Lin3  Chiu-Ching Huang3  | |
[1] Division of Nephrology, National Taiwan University Hospital, Taipei, Taiwan;Hsin-Jen Hospital, Taipei, Taiwan;The Kidney Institute and Division of Nephrology, China Medical University Hospital, Taichung, Taiwan;Graduate Institute of Clinical Medical Science, College of Medicine, China Medical University, Taichung, Taiwan; | |
关键词: Phosphate binder; Sevelamer; Fetuin-A; Hemodialysis; CKD; ESRD; | |
DOI : 10.1186/s12882-016-0245-3 | |
received in 2015-05-30, accepted in 2016-03-17, 发布年份 2016 | |
来源: Springer | |
【 摘 要 】
BackgroundFetuin-A is known as a circulating inhibitor of vascular calcification. Factors associated with serum fetuin-A concentrations after long-term use of different phosphate binders in hemodialysis patients is still uncertain.MethodsIn the post-hoc study, we analyzed serum fetuin-A and biochemical factors (Ca, P, i-PTH, hsCRP, TG, LDL-C) in 50 hemodialysis patients, who completed a 48-week, open-Label, controlled randomized parallel-group study. 23 patients received sevelamer and 27 patients received calcium carbonate.ResultsAfter the 48-week treatment, the sevelamer group had less serum calcium increment, less iPTH decrement, more ALK-P increment, more hsCRP decrement and more LDL-C decrement. There was no significant difference in the serum fetuin-A decrement between two groups. Decreased serum fetuin-A levels were found after 48-week treatment in both groups: from 210.61 (104.73) to 153.85 (38.64) ug/dl, P = 0.003 in sevelamer group, from 203.95 (107.87) to 170.90 (58.02) ug/mL, P =0.002 in calcium group. The decrement in serum fetuin-A (Δfetuin-A) levels was associated with ΔCa (ρ = - 0.230, P = 0.040), ΔiPTH (ρ = 0.306, P = 0.031) and Δalbumin (ρ = 0.408, P = 0.003), not associated with sevelamer use, ΔP and ΔhsCRP.ConclusionAfter long-term sevelamer or calcium carbonate treatment, both groups of maintenance HD patients had lower serum fetuin-A levels. Serum levels of increased calcium, decreased iPTH and decreased albumin were associated with the serum fetuin-A decrement.
【 授权许可】
CC BY
© Lin et al. 2016
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO202311101608537ZK.pdf | 504KB | download |
【 参考文献 】
- [1]
- [2]
- [3]
- [4]
- [5]
- [6]
- [7]
- [8]
- [9]
- [10]
- [11]
- [12]
- [13]
- [14]
- [15]
- [16]
- [17]
- [18]
- [19]
- [20]
- [21]
- [22]
- [23]
- [24]
- [25]
- [26]
- [27]
- [28]